Literature DB >> 7083162

Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice.

D L Dexter, G M Matook, P A Meitner, H A Bogaars, G A Jolly, M D Turner, P Calabresi.   

Abstract

Two human pancreatic cancer lines, RWP-1 and RWP-2, have been established from 2 patients with primary pancreatic cancer metastatic to the liver. The patients' tumors, the xenografted tumors, and tumors obtained by inoculation of nude mice with cultured RWP-1 and RWP-2 cells are all moderately-well-differentiated ductal cell adenocarcinomas. Ultrastructural analysis supports the tissue histopathology findings. Xenografts of RWP-1 tumors double every 10 days, whereas the doubling time of RWP-2 xenografts is 22 days. Both tumors contain mucin. RWP-1 and RWP-2 cells have a doubling time in culture of 45 hr and form colonies in soft agar. RWP-1 cultures appear to be morphologically heterogeneous; two distinct epithelial cell types can be identified. RWP-1 and RWP-2 have modal chromosome numbers of 64 and 62, respectively. Appreciable levels of glucose-6-phosphate dehydrogenase and lactic dehydrogenase were found in both cell lines and xenografts. RWP-1 and RWP-2 cells produce appreciable amounts of carcinoembryonic antigen, 1090 and 414 ng/10(6) cells, respectively.

Entities:  

Mesh:

Year:  1982        PMID: 7083162

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.

Authors:  W R Gower; R M Risch; C V Godellas; P J Fabri
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

2.  Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.

Authors:  H J Kahn; H Yeger; R Loftus; M H Goldrosen
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

3.  Establishment and characterization of a new transplantable pancreatic cancer xenograft (PZX-5) in immunosuppressed mice.

Authors:  A Zalatnai; J Bocsi; F Timár; I Babó
Journal:  Int J Pancreatol       Date:  1998-02

4.  A new human pancreatic carcinoma cell line developed for adoptive immunotherapy studies with lymphokine-activated killer cells in nude mice.

Authors:  B J Drucker; F M Marincola; D Y Siao; T A Donlon; C D Bangs; W D Holder
Journal:  In Vitro Cell Dev Biol       Date:  1988-12

5.  New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens.

Authors:  M Heike; O Röhrig; H E Gabbert; R Moll; K H Meyer zum Büschenfelde; W G Dippold; A Knuth
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity.

Authors:  Xavier Bofill-De Ros; Meritxell Gironella; Cristina Fillat
Journal:  Mol Ther       Date:  2014-06-04       Impact factor: 11.454

7.  Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.

Authors:  Carlos A Orozco; Neus Martinez-Bosch; Pedro E Guerrero; Judith Vinaixa; Tomás Dalotto-Moreno; Mar Iglesias; Mireia Moreno; Magdolna Djurec; Françoise Poirier; Hans-Joachim Gabius; Martin E Fernandez-Zapico; Rosa F Hwang; Carmen Guerra; Gabriel A Rabinovich; Pilar Navarro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-03       Impact factor: 11.205

8.  The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis.

Authors:  George N Tzanakakis; Elias Krambovitis; Aristidis M Tsatsakis; Michael P Vezeridis
Journal:  Int J Gastrointest Cancer       Date:  2002

9.  Reactivity of monoclonal anti-human pancreatic carcinoma antibodies AR2-20 and AR1-28 with tumors of nonpancreatic origin.

Authors:  J Chin; R Zuna; F Miller
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

Review 10.  Considerations in the use of nude mice for cancer research.

Authors:  F E Sharkey; J Fogh
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.